Overcoming Obstacles of the Canadian Drug Regulatory Landscape

In this webinar we will discuss each obstacle in detail and deliver tips that will improve your efficiency and increase opportunities for successful market access, Through this presentation, We will explore reasons why the Canadian market should not be overlooked and the benefits of including Canada in strategic drug development initiatives.

Susanne Picard
Instructor:
Susanne Picard
Date:
Tuesday, May 28, 2019
Time:
08:00 AM PDT | 11:00 AM EDT
Duration:
60 Minutes

More Trainings by this Expert   Product Id : 502454

Price Details
$150 Live
$290 Corporate Live
$190 Recorded
$390 Corporate Recorded
Combo Offers
Live + Recorded
$289 $340 Live + Recorded
Corporate (Live + Recorded)
$599 $680 Corporate
(Live + Recorded)
Price Detail Options
Overview:

Learn what common obstacles are in the Canadian Drug Development and Approval Process and how to avoid them or manage them efficiently should they occur.

We will discuss each obstacle in detail and deliver tips that will improve your efficiency and increase opportunities for successful market access. Through this presentation, you will develop a comprehensive understanding of the Drug Approval Process and in parallel examine major misconceptions and misunderstandings.

Our focus will be on key strategic considerations at various stages of the Drug Development Process as well as on demystifying the broader principals of the drug registration approach in Canada.

Why should you Attend: We will explore reasons why the Canadian market should not be overlooked and the benefits of including Canada in strategic drug development initiatives.

We will share insights and practical examples that facilitate a positive, proactive and transparent interaction with Health Canada, and provide strategies for avoiding obstacles and managing them efficiently should they occur.

Areas Covered in the Session:

  • A comprehensive overview of the Drug Approval Process, including major misconceptions and misunderstandings
  • What common obstacles are in the Canadian Drug Development and Approval Process and how to avoid / manage them
  • Key strategic considerations at various stages of the Drug Development Process
  • The broader principals of the drug registration approach in Canada
  • Tips that will improve your efficiency and increase opportunities for successful market access

Who Will Benefit:
  • Pharma
  • Biotech Executives
  • Decision Makers
  • Study Sponsors


Speaker Profile
Susanne Picard Founder and President of SPharm, is a sought-after expert on all aspects of the regulatory landscape. SPharm is a leading regulatory affairs consultancy headquartered in Canada that services clients around the globe.




Your Recently Viewed Webinars

Payment Methods

Contact Us

NetZealous LLC,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.

Information

  Refund Policy
  +1-800-447-9407
  Fax: 302 288 6884
  support@compliance4All.com